Michael E. Severino

2016

In 2016, Michael E. Severino earned a total compensation of $7.2M as Executive Vice President, Research & Development and Chief Scientific Officer at AbbVie, a 10% increase compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$375,080
Non-Equity Incentive Plan$1,596,000
Option Awards$850,908
Salary$960,969
Stock Awards$3,359,376
Other$101,530
Total$7,243,863

Severino received $3.4M in stock awards, accounting for 46% of the total pay in 2016.

Severino also received $375.1K of change in pension value and nonqualified deferred compensation earnings, $1.6M in non-equity incentive plan, $850.9K in option awards, $961K in salary and $101.5K in other compensation.

Rankings

In 2016, Michael E. Severino's compensation ranked 883rd out of 14,075 executives tracked by ExecPay. In other words, Severino earned more than 93.7% of executives.

ClassificationRankingPercentile
All
883
out of 14,075
94th
Division
Manufacturing
287
out of 5,489
95th
Major group
Chemicals And Allied Products
75
out of 1,895
96th
Industry group
Drugs
48
out of 1,538
97th
Industry
Pharmaceutical Preparations
40
out of 1,176
97th
Source: SEC filing on March 19, 2018.

Severino's colleagues

We found four more compensation records of executives who worked with Michael E. Severino at AbbVie in 2016.

2016

Richard Gonzalez

AbbVie

Chief Executive Officer

2016

William Chase

AbbVie

Chief Financial Officer

2016

Laura Schumacher

AbbVie

General Counsel

2016

Carlos Alban

AbbVie

Executive Vice President, Global Commercial Operations

News

You may also like